ProMetic Life Sciences Inc. (OTCMKTS:PFSCF – Get Rating)’s share price passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $5.47 and traded as low as $5.47. ProMetic Life Sciences shares last traded at $5.47, with a volume of 200 shares traded.
ProMetic Life Sciences Trading Down 3.6 %
The business has a 50-day moving average price of $5.47 and a 200-day moving average price of $5.47.
About ProMetic Life Sciences
Prometic Life Sciences Inc operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals.
Featured Articles
- Get a free copy of the StockNews.com research report on ProMetic Life Sciences (PFSCF)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for ProMetic Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProMetic Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
